Left Ventricular Remodeling
9
0
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Prediction of LVAR and MACE in AMI Though Plasma Multiomics Analysis
Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER)
A Study of VentriGel in Post-MI Patients
IMproving reModeling in Acute myoCardial Infarction Using Live and Asynchronous TElemedicine.
Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction
Danlou Tablets to Prevent Left Ventricular Remodeling
Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling
Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling